As of Sep 26
| -0.26 / -0.31%|
The 15 analysts offering 12-month price forecasts for Charles River Laboratories International Inc have a median target of 92.00, with a high estimate of 106.00 and a low estimate of 75.00. The median estimate represents a +11.52% increase from the last price of 82.50.
The current consensus among 20 polled investment analysts is to Hold stock in Charles River Laboratories International Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.